Algorithmic Bioscience Incorporated is a Delaware corporation that was established in 2003. The corporation is privately owned with principal offices located in Pennsylvania. The company's overall missions are to:

(a) Process previously undifferentiated information for clients, so as to elucidate the associations and/ or causal relationships that exist between independently measured predictor variables and specific outcomes that are of interest to prospective customers;

(b) Develop mathematical models, descriptions, equations and algorithms that can be utilized for ongoing decision-support by clients, and;

(c) Establish formal/ quantitative processes for analyzing both proprietary and public-domain data, so as to establish individualized risk-benefit relationships in order to make such data useful to specific subgroups, as well as to particular individuals for decision-making support.

To these ends, Algorithmic Bioscience Incorporated utilizes a sophisticated system of advanced evidence-based processing techniques to collect, analyze, test and validate the potential associations that may exist between multiple input determinants and the occurrence of subsequent independent and/ or potentially overlapping outcomes and results that are of particular interest to clients. The company specializes in all phases of data acquisition, processing, analysis, and application, as well as the development of user-friendly interactive systems for both the collection of prospective information and for the return of individualized risk-benefit profiles/ results to specific users. Both data acquisition and the return of individualized results can be accomplished either via Internet-based world-wide-web delivery systems or by individualized computer or network programming. To date, a major focus of the company's activities has involved the analysis and individualized subgroup application of findings that have resulted from the systematic assessment and evaluation of large, de-identified medical databases. The development of quantitative group-specific risk-benefit profiles, and the elucidation/ quantification of system-specific failure risk tolerance are the strengths of the company's current analytical expertise and techniques.

For further information concerning Algorithmic Bioscience Incorporated, or for individualized quotations concerning projects that may be of interest to either existing or future clients and business partners, please contact us either by e-mail by using the "Contact Us" button in the top row tool bar, or by written correspondence at the following address:

Algorithmic Bioscience Incorporated
Business Development Department
P.O. Box 1024
Wexford, PA 15090-1024